International Assets Investment Management LLC purchased a new position in shares of Smith & Nephew plc (NYSE:SNN – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 26,243 shares of the medical equipment provider’s stock, valued at approximately $716,000.
A number of other hedge funds and other institutional investors have also modified their holdings of the company. Highland Capital Management LLC grew its holdings in shares of Smith & Nephew by 1.8% during the fourth quarter. Highland Capital Management LLC now owns 24,915 shares of the medical equipment provider’s stock worth $680,000 after buying an additional 450 shares in the last quarter. Legacy Wealth Asset Management LLC grew its holdings in shares of Smith & Nephew by 3.8% during the third quarter. Legacy Wealth Asset Management LLC now owns 15,026 shares of the medical equipment provider’s stock worth $372,000 after buying an additional 546 shares in the last quarter. Inspire Advisors LLC grew its holdings in shares of Smith & Nephew by 7.4% during the third quarter. Inspire Advisors LLC now owns 13,286 shares of the medical equipment provider’s stock worth $329,000 after buying an additional 919 shares in the last quarter. SVB Wealth LLC grew its holdings in shares of Smith & Nephew by 8.4% during the third quarter. SVB Wealth LLC now owns 12,487 shares of the medical equipment provider’s stock worth $309,000 after buying an additional 970 shares in the last quarter. Finally, Allworth Financial LP grew its holdings in shares of Smith & Nephew by 1,566.2% during the third quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 1,065 shares in the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.
Smith & Nephew Price Performance
SNN opened at $24.57 on Thursday. The company’s 50 day simple moving average is $26.14 and its 200 day simple moving average is $25.98. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72. Smith & Nephew plc has a 1 year low of $21.52 and a 1 year high of $33.08.
Smith & Nephew Dividend Announcement
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.
View Our Latest Stock Analysis on SNN
Smith & Nephew Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
See Also
- Five stocks we like better than Smith & Nephew
- Insider Buying Explained: What Investors Need to Know
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is a Death Cross in Stocks?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- When to Sell a Stock for Profit or Loss
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN – Free Report).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.